Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

McGill University

$359,549.00

Developing and validating biomarkers for chronic pain

EF 2020-21

Résumé
The cause of chronic pain remains elusive and the development of better diagnostic tools is among the most promising targets for improving pain management. This proposal means to leverage recent advances in artificial intelligence applied to brain imaging data to develop objective biomarkers for chronic pain. Magnetic resonance imaging is a brain imaging method that has been successfully used for decoding thoughts, feelings, and dreams from brain activity. Despite its potential for capturing pain, brain imaging has yet provided clinically useful tools for diagnosis, prognostication, and prediction of chronic pain. The advent of openly available very large datasets provides new opportunities to use artificial intelligence to develop biomarkers for chronic pain. The main objective of this proposal is to develop and validate brain-based biomarkers using data from a large number of individuals and to test the generalization of this marker to another data set. The secondary objective is to test the stability of the biomarkers across contexts and imaging sessions across time. More precisely, we will test if the expression of the biomarker is changing in patients receiving placebo or pharmacological treatment. This will help us determining if our biomarker can predict and/or track pain analgesia following treatments. Furthermore, we will test if our biomarkers can predict the prognostic of chronic pain in subacute back pain individuals one year later. A biomarker for chronic pain would represent an objective measurement of the pathology that can be used for both clinical and research contexts. This would ultimately represent an important advancement for prevention strategies and may ultimately lead to improved chronic pain management as well as a reduction of harms for patients.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
435308
Name
Vachon-Presseau Etienne
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Behavioural Sciences - B-2
Projecttitle
Developing and validating biomarkers for chronic pain
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$359,549
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Biomarker; Chronic Pain; Diagnostic Tool; Machine Learning; Uk Biobank
Abstract
The cause of chronic pain remains elusive and the development of better diagnostic tools is among the most promising targets for improving pain management. This proposal means to leverage recent advances in artificial intelligence applied to brain imaging data to develop objective biomarkers for chronic pain. Magnetic resonance imaging is a brain imaging method that has been successfully used for decoding thoughts, feelings, and dreams from brain activity. Despite its potential for capturing pain, brain imaging has yet provided clinically useful tools for diagnosis, prognostication, and prediction of chronic pain. The advent of openly available very large datasets provides new opportunities to use artificial intelligence to develop biomarkers for chronic pain. The main objective of this proposal is to develop and validate brain-based biomarkers using data from a large number of individuals and to test the generalization of this marker to another data set. The secondary objective is to test the stability of the biomarkers across contexts and imaging sessions across time. More precisely, we will test if the expression of the biomarker is changing in patients receiving placebo or pharmacological treatment. This will help us determining if our biomarker can predict and/or track pain analgesia following treatments. Furthermore, we will test if our biomarkers can predict the prognostic of chronic pain in subacute back pain individuals one year later. A biomarker for chronic pain would represent an objective measurement of the pathology that can be used for both clinical and research contexts. This would ultimately represent an important advancement for prevention strategies and may ultimately lead to improved chronic pain management as well as a reduction of harms for patients.
Competitiondate
202010
Approvedterm2
3 yrs 6 mths
Pinamesdelim
Vachon-Presseau, Etienne
Approvedterm
3 ans 6 mois
Cihrcontribution2
~ $359,549~ $0~